Syndax Pharmaceuticals SNDX Noncash Operating Lease Expense
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept sndx:NoncashOperatingLeaseExpense.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Syndax Pharmaceuticals's noncash operating lease expense?
- Syndax Pharmaceuticals (SNDX) reported noncash operating lease expense of $130K in Q1 2026.
- How has Syndax Pharmaceuticals's noncash operating lease expense changed year-over-year?
- Syndax Pharmaceuticals's noncash operating lease expense decreased by 41.2% year-over-year, from $221K to $130K.